BRIEF published on 05/22/2025 at 07:05, 1 year 2 months ago Relief Therapeutics Secures FDA Rare Pediatric Disease Designation for RLF-TD011 FDA Relief Therapeutics RLF-TD011 Epidermolysis Bullosa Rare Pediatric Disease
PRESS RELEASE published on 05/22/2025 at 07:00, 1 year 2 months ago Relief Therapeutics Receives FDA Rare Pediatric Disease Designation for RLF-TD011 Relief Therapeutics granted FDA Rare Pediatric Disease Designation for RLF-TD011 in treating epidermolysis bullosa, a rare genetic skin disorder. Potent antimicrobial & anti-inflammatory activity shown FDA Relief Therapeutics RLF-TD011 Epidermolysis Bullosa Rare Pediatric Disease Designation
BRIEF published on 05/15/2025 at 07:05, 1 year 2 months ago Relief Therapeutics Announces 2025 AGM Agenda Annual General Meeting Financial Statements Shareholder Voting Board Re-election Compensation Approval
PRESS RELEASE published on 05/15/2025 at 07:00, 1 year 2 months ago Relief Therapeutics Publishes 2025 Annual General Meeting Agenda Relief Therapeutics announces agenda for its 2025 Annual General Meeting featuring key resolutions and re-elections. Meeting scheduled for June 12 in Geneva, Switzerland Shareholders Switzerland Relief Therapeutics Agenda 2025 Annual General Meeting
BRIEF published on 04/10/2025 at 07:05, 1 year 3 months ago Relief Therapeutics Announces 2024 Financial Results and Strategic Progress Biopharmaceutical Relief Therapeutics Rare Diseases 2024 Financial Results Pipeline Progress
PRESS RELEASE published on 04/10/2025 at 07:00, 1 year 3 months ago Relief Therapeutics Reports 2024 Financial Results and Provides Corporate Update Relief Therapeutics reports 2024 financial results and provides a corporate update, emphasizing operational achievements, pipeline momentum, and strengthened financial position Biopharmaceutical Corporate Update Relief Therapeutics Rare Diseases 2024 Financial Results
BRIEF published on 03/06/2025 at 07:05, 1 year 4 months ago Relief Therapeutics Ends Merger Discussions with Renexxion Shareholder Value Relief Therapeutics Strategic Objectives Renexxion Merger Termination
PRESS RELEASE published on 03/06/2025 at 07:00, 1 year 4 months ago Relief Therapeutics Announces Conclusion of Merger Discussions with Renexxion Relief Therapeutics terminates merger discussions with Renexxion after failing to meet key conditions. Company remains well-positioned with robust pipeline and cash reserves Relief Therapeutics Cash Reserves Therapeutic Pipeline Renexxion Merger Discussions
BRIEF published on 02/11/2025 at 07:05, 1 year 5 months ago European Patent Office Grants Relief Therapeutics Patent for RLF-TD011 Biopharmaceuticals Relief Therapeutics RLF-TD011 European Patent Epidermolysis Bullosa
PRESS RELEASE published on 02/11/2025 at 07:00, 1 year 5 months ago Relief Therapeutics Announces European Patent Office Decision to Grant Patent for RLF-TD011 Relief Therapeutics obtains European Patent Office grant for RLF-TD011, securing patent protection for epidermolysis bullosa treatment. Company advances wound care solution Relief Therapeutics European Patent Office Epidermolysis Bullosa Wound Treatment RLD-TD011
Published on 08/04/2026 at 12:00, 38 minutes ago Golden Minerals Announces Formation of Sand Canyon Joint Venture
Published on 08/04/2026 at 12:00, 38 minutes ago Zomedica Launches the PulseVet Acoustic Muffler(TM) Accessory for PulseVet(R) Shock Wave System
Published on 08/04/2026 at 09:10, 3 hours 28 minutes ago HM Exploration Drills 18.45 Metres of 1.14% Cu, 2.42 % Zn, 16.74 g/t Ag and 0.32 g/t Au in Upper Lens; 5.42m of 1.99% Cu, 1.66% Zn, 15.39g/t Ag and 0.8g/t Au in Lower lens at Lewis Pilley's
Published on 08/04/2026 at 09:05, 3 hours 33 minutes ago BioNxt Provides Development, Intellectual Property and Commercial Update Across Sublingual Drug Delivery Pipeline
Published on 08/03/2026 at 23:00, 13 hours 38 minutes ago Viemed Healthcare Announces Second Quarter 2026 Financial Results
Published on 08/04/2026 at 12:00, 38 minutes ago Verve Wins 2026 ADWEEK Tech Stack Award for Mobile Product/Platform
Published on 08/04/2026 at 11:45, 53 minutes ago 2026 World Manufacturing Convention Releases Teaser, Extending a Global Invitation to Innovate Together
Published on 08/04/2026 at 11:42, 56 minutes ago Edison Group reaches global audience of over 8.5 million
Published on 08/04/2026 at 11:20, 1 hour 17 minutes ago Indusface Introduces SwyftComply AI, Defining the Next Era of Application Security with Autonomous Vulnerability Remediation
Published on 08/04/2026 at 08:15, 4 hours 23 minutes ago Covivio - Conditions of availability of the 2026 Half-year report
Published on 08/03/2026 at 18:45, 17 hours 53 minutes ago Covivio - Information on total number of voting rights and share capital
Published on 08/03/2026 at 17:45, 18 hours 53 minutes ago Monthly disclosure of the total number of shares and voting rights - July 2026
